Previous 10 | Next 10 |
S3 Partners ran an intriguing screen to find the most crowded shorts in the market. In looking at the stocks under attack, the firm said a short can be considered to be "crowded" if there are large amount of dollars at risk on the short side, a large proportion of a stock's float is being sho...
Eight new deals announced last week. Chicken Soup acquires Redbox in a 'take-under' at a massive discount. Following Elon Musk's tweet last week, stating that the Twitter deal is temporarily on hold, Twitter shares fell as low as $40.01 on Friday, May 13, 2022. For further d...
Do You Have These Top Biotech Stocks On Your Watchlist? Depending on your investment appetite, the stock market offers various types of opportunities. Biotech stocks have a reputation for being a high-risk, high-reward sector to invest in. This is an industry that includes compa...
Global Blood Therapeutics (NASDAQ:GBT) may be a potential acquisition candidate in the biotech space following Pfizer (PFE)'s deal to acquire Biohaven Pharmaceutical for about $11.6 billion, according to a Wedbush analyst. "In light of Pfizer’s $12 billion acquisition of Biohaven Pharm...
Biohaven Pharmaceuticals Holding Company Ltd. ( NYSE: BHVN ) was up 70% after the company and Pfizer Inc. ( NYSE: PFE ) entered a definitive agreement under which Pfizer would acquire the NURTEC ODT maker. NURTEC ODT is a novel dual-acting medicine for migraine that is l...
NEW YORK, NY / ACCESSWIRE / May 11, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: ServiceSource International, Inc. (NA...
The major U.S. equity indices put in a mixed performance on Tuesday, stabilizing after the declines that have rocked Wall Street in recent days. The S&P 500 and Nasdaq finished higher, while the Dow posted mild losses. Food distribution stocks were among the gainers on the day. Strong ear...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Based in New Haven, Connecticut, biotech company Biohaven Pharmaceutical (NYSE: BHVN ) is soaring today after announcing its acquisition by Pfizer (NYSE: PFE ). Currently, BHVN stock is up nearly 70% on a...
Shares of Biohaven Pharmaceutical (NYSE: BHVN) rocketed 68% on Tuesday after the biopharmaceutical company struck a deal to be acquired by Pfizer (NYSE: PFE) . Biohaven is a leader in the treatment of migraines -- often intensely painful headaches that affect 1 billion p...
Despite a slew of investment houses cutting price targets for CRISPR Therapeutics (NASDAQ:CRSP) Tuesday in the wake of its Q1 2022 results, shares closed up 9%. One reason for the rise is social media speculation that following Pfizer's (PFE) announcement Tuesday it would acquire Biohave...
News, Short Squeeze, Breakout and More Instantly...
Biohaven Pharmaceutical Holding Company Ltd. Company Name:
BHVN Stock Symbol:
NYSE Market:
Biohaven Pharmaceutical Holding Company Ltd. Website:
2024-07-24 06:30:09 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for BHVN on July 24, 2024 04:48AM ET. BHVN was trading at $37.81 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 6 - Buy reco...
2024-07-24 06:00:03 ET Terence Flynn from Morgan Stanley issued a price target of $58.00 for BHVN on 2024-07-24 04:48:00. The adjusted price target was set to $58.00. At the time of the announcement, BHVN was trading at $37.81. The overall price target consensus is at $4...
2024-07-20 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...